Robuta

Sponsor of the Day: Jerkmate

https://www.biorxiv.org/content/10.1101/2024.06.02.596989v1.article-info Persistent Neurological Deficits in Mouse PASC Reveal Antiviral Drug Limitations | bioRxiv Post-Acute Sequelae of COVID-19 (PASC) encompasses persistent neurological symptoms, including olfactory and autonomic dysfunction. Here, we report chronic... mouse pasc reveal antiviral drug limitations persistent neurological deficits biorxiv https://www.biorxiv.org/content/10.1101/2024.06.02.596989v1 Persistent Neurological Deficits in Mouse PASC Reveal Antiviral Drug Limitations | bioRxiv Post-Acute Sequelae of COVID-19 (PASC) encompasses persistent neurological symptoms, including olfactory and autonomic dysfunction. Here, we report chronic... mouse pasc reveal antiviral drug limitations persistent neurological deficits biorxiv https://chemanager-online.com/en/books/trends-in-antiviral-drug-development Trends in Antiviral Drug Development • CHEManager is the market-leading medium for the management... Trends in Antiviral Drug Development market leading medium antiviral drug trends development chemanager https://www.nature.com/articles/s41467-025-56902-x?error=cookies_not_supported&code=6de713c6-b6cc-4643-b3e6-0bb22c231ace Design of quinoline SARS-CoV-2 papain-like protease inhibitors as oral antiviral drug candidates |... Feb 13, 2025 - The ever-evolving SARS-CoV-2 variants necessitate the development of additional oral antivirals. This study presents the systematic design of... sars cov 2 antiviral drug design papain like https://www.biorxiv.org/content/10.1101/2024.06.02.596989v1.full Persistent Neurological Deficits in Mouse PASC Reveal Antiviral Drug Limitations | bioRxiv Post-Acute Sequelae of COVID-19 (PASC) encompasses persistent neurological symptoms, including olfactory and autonomic dysfunction. Here, we report chronic... mouse pasc reveal antiviral drug limitations persistent neurological deficits biorxiv